| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/23/2007 | US20070196354 Method of treating diabetes by inhibiting degradation of at least one of crebl1, atf6, and hnf-4 alpha by htra |
| 08/23/2007 | DE102006008074A1 Behandlung von Krebs mit Geruchsrezeptor-Liganden Treatment of cancer with olfactory receptor ligands |
| 08/23/2007 | CA2652310A1 Human telomerase reverse transcriptase peptides |
| 08/23/2007 | CA2645734A1 Method of treating inflammatory diseases |
| 08/23/2007 | CA2642751A1 Proteasom or ups inhibitor for treating infections with influenza viruses |
| 08/23/2007 | CA2641917A1 Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin |
| 08/23/2007 | CA2633588A1 Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same |
| 08/22/2007 | EP1820854A2 JNK3 modulators and methods of use |
| 08/22/2007 | EP1820515A1 Nitrogen-containing fused ring compound and use thereof |
| 08/22/2007 | EP1820514A2 Therapeutic compositions that produce an immune response by altering the antigen |
| 08/22/2007 | EP1820500A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 08/22/2007 | EP1820495A2 Microspheres for active embolization |
| 08/22/2007 | EP1820442A1 Noninvasive measurements of chemical substances |
| 08/22/2007 | EP1819724A1 Compositions containing beta 2-glycoprotein i for the prevention and/or treatment of vascular disease |
| 08/22/2007 | EP1819364A2 Immunomodulatory compositions, combinations and methods |
| 08/22/2007 | EP1819361A2 Pharmaceutical combinations |
| 08/22/2007 | EP1819329A2 Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases |
| 08/22/2007 | EP1819328A1 Adjunctive therapy for depression |
| 08/22/2007 | EP1819226A2 Immunostimulatory combinations and methods |
| 08/22/2007 | EP1572892A4 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/22/2007 | EP1499334B1 Petasin-free polar petasites extract fractions and their use to treat pain |
| 08/22/2007 | EP1476470B1 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments |
| 08/22/2007 | EP1467970B1 Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors |
| 08/22/2007 | EP1467728B1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 08/22/2007 | EP1402024B1 Templated molecules and methods for using such molecules |
| 08/22/2007 | EP1379513B1 Prodrugs of cox-2 inhibitors |
| 08/22/2007 | EP1359920B1 Uses of oral formulations for the treatment of female sexual dysfunction |
| 08/22/2007 | EP1242009B1 Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds |
| 08/22/2007 | EP1227804B1 Use of eplerenone for treating restenosis |
| 08/22/2007 | EP1157040B1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 08/22/2007 | EP1017846B1 Control of immune responses by modulating activity of glycosyltransferases |
| 08/22/2007 | EP0925069B1 Use of cetrorelix for the treatment of benign prostate hypertrophy and prostate cancer |
| 08/22/2007 | CN1332954C Dipeptidyl peptidase IV effectors |
| 08/22/2007 | CN1332715C Novel medicinal use of proteinase inhibior for preventing and curing lang disease |
| 08/22/2007 | CN1332713C Methods for inhibiting brain tumor growth |
| 08/22/2007 | CN101023119A Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
| 08/22/2007 | CN101023072A Piperidinyl targeting compounds that selectively bind integrins |
| 08/22/2007 | CN101022823A Physiologically active composition based on collagen |
| 08/22/2007 | CN101022814A Composition containing swelling agent comprising swellable water-soluble polysaccharide and food, obesity preventive, and constipation alleviator each containing the composition |
| 08/22/2007 | CN101022785A External preparation of s/o type |
| 08/22/2007 | CN101020061A Prepn process of ultrasonically controlled releasing micro gel containing medicine |
| 08/22/2007 | CN101020057A Composition for treating solid tumor |
| 08/22/2007 | CN101020056A Combined application of artemisinin and its derivative and antibiotic medicine |
| 08/22/2007 | CN101019856A Allonic acid compound possessing antitumor activity and its prepn process, prepn and use |
| 08/22/2007 | CN101019831A Slow releasing anticancer prepn containing vasoinhibitor |
| 08/22/2007 | CN101019830A Anticancer composition containing phosphoinositide-3-kinase inhibitor and topomerase inhibitor |
| 08/22/2007 | CN101019829A Slow releasing anticancer prepn containing vasoinhibitor |
| 08/22/2007 | CN101019828A Anticancer composition containing both phosphoinositide-3-kinase inhibitor and hormone medicine |
| 08/22/2007 | CN101019827A Anticancer composition containing both phosphoinositide-3-kinase inhibitor and alkylating agent |
| 08/21/2007 | US7259278 Anti-S-phase tubulin ligands |
| 08/21/2007 | US7259247 Against the costimulatory surface molecule, natural or synthetic ligands, agonists or antagonists of the surface molecule. |
| 08/21/2007 | US7259188 Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators |
| 08/21/2007 | US7259181 β crystalline form of perindopril tert-butylamine salt |
| 08/21/2007 | US7259143 Administering an appropriate dosage schedule of a bone calcium resorption inhibitor and a toxic dose of a vitamin d without developing hypercalcemia |
| 08/21/2007 | US7259138 Anti-tumor agents |
| 08/21/2007 | US7258973 Oligonucleotide sequences for use in the diagnosis and treatment of colon cancer |
| 08/21/2007 | US7258876 applying a mixture of melaleuca alternifolia extract oil, an immunostimulant and an antioxidant; treats most every type of infection caused by pathogenic organisms with little or no side effects. |
| 08/21/2007 | US7258872 Chromone enteric release formulation |
| 08/21/2007 | US7258871 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
| 08/21/2007 | US7258859 Method for the treatment of multiple sclerosis |
| 08/21/2007 | CA2493885C Use of sodium channel blocking compounds and aspirin in manufacturing drugs for producing synergistically analgesic effect in mammals |
| 08/21/2007 | CA2388610C Oral transmucosal drug dosage using solid solution |
| 08/21/2007 | CA2387600C Novel fusidic acid derivatives |
| 08/21/2007 | CA2320368C Composition comprising theanine |
| 08/21/2007 | CA2285054C Immobilized activity stabilized lhrh antagonist complexes, method for the production thereof |
| 08/21/2007 | CA2247966C Murine .alpha.(1,3)fucosyltransferase fuc-tvii, dna encoding the same and uses thereof |
| 08/21/2007 | CA2150940C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 08/16/2007 | WO2007092802A1 Method for treating hiv infection through co-administration of tipranavir and gs 9137 |
| 08/16/2007 | WO2007092616A2 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto |
| 08/16/2007 | WO2007092458A1 Antidotes to exogenous neurotoxic agents |
| 08/16/2007 | WO2007092270A2 Combination therapy for coronary artery disease |
| 08/16/2007 | WO2007091719A1 Concomitant anti-gpvi antibody therapy and novel medicinal use thereof |
| 08/16/2007 | WO2007091622A1 Anti-cancer pharmaceutical composition |
| 08/16/2007 | WO2007091501A1 Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3-propanaediol derivative as active ingredient, and method for treatment of inflammatory bowel disease |
| 08/16/2007 | WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same |
| 08/16/2007 | WO2007091328A1 Method for treatment of lung cancer |
| 08/16/2007 | WO2007090862A2 Neutral sphingomyelinase-3 and its use |
| 08/16/2007 | WO2007012841A3 Compositions comprising monobutyrin |
| 08/16/2007 | WO2006124753A3 Antipyretic agents against vr1-antagonist-induced increases in body temperature |
| 08/16/2007 | WO2006115509A3 Small molecule immunopotentiators and assays for their detection |
| 08/16/2007 | WO2006093784A3 Dosage forms of antibiotics and combinations of antibiotics ans symptomatic relief agents |
| 08/16/2007 | WO2006055660A3 Method for treating hiv infection through co-administration of tipranavir and uk-427, 857 |
| 08/16/2007 | WO2005037260A3 Use of adrenergic alphaze antagonists for the treatment of vasomotor symptoms |
| 08/16/2007 | WO2004091609A3 Phosphodiesesterase 4 inhibitors for the treatment of a cognitive deficit |
| 08/16/2007 | WO2004060302A3 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 08/16/2007 | WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments |
| 08/16/2007 | US20070191478 Methods of treating cardio pulmonary diseases with NO group compounds |
| 08/16/2007 | US20070191438 Methods for the treatment of hypertension |
| 08/16/2007 | US20070191412 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
| 08/16/2007 | US20070191401 Transplant rejection, autoimmune disease, autoimmune disease |
| 08/16/2007 | US20070191350 Combinations comprising alpha-2-delta ligands |
| 08/16/2007 | US20070191338 Combinations comprising staurosporines |
| 08/16/2007 | US20070191324 Methods for treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist |
| 08/16/2007 | US20070191320 Methods of treatment for female sexual arousal disorder |
| 08/16/2007 | US20070191319 Treatment of conditions that present with low bone mass by continuous combination therapy with selective prostaglandin ep4 receptor agonists and an estrogen |
| 08/16/2007 | US20070191291 Compound antibacterial drugs comprising n-acetyl-d-glucosamine |
| 08/16/2007 | US20070191280 High Purity Lipopeptides |
| 08/16/2007 | US20070190567 Treatment for asthma and allergy |
| 08/16/2007 | US20070190185 Plant extract mixtures and their uses |
| 08/16/2007 | US20070190128 Suitable for favoring the intracellular delivery of pharmacologically active compounds, facilitating their transmembrane transport, or for promoting their interaction with specific cell membrane sites (receptors) |